Publication | Closed Access
Phase II trial of flavopiridol, a cyclin dependent kinase inhibitor, in untreated metastatic malignant melanoma
89
Citations
22
References
2004
Year
OncologyPhase Ii TrialMedicineMelanomaPharmacotherapyAnti-cancer AgentCancer TreatmentPharmacologyRadiation Oncology
| Year | Citations | |
|---|---|---|
Page 1
Page 1